MedTech Integrates 2021 Track 1

DETECTION

Disease detection is key to diagnosis and treatment. How are we accelerating the clinical translation of MedTech, and is it impacting wealth as well as health?

Welcome and opening remarks

Martino Picardo, Chairman, Discovery Park

An interview with Darren Curry

Interview conducted by Paul Wicks, Independent Consultant, Wicks Digital Health

An interview with Simon Donovan

Interview conducted by Martino Picardo, Chairman, Discovery Park

Listen to your heart

Predicting, diagnosing and monitoring cardiac conditions using health tech and wearables.

FACILITATED BY

MIKE HANNAY | Managing Director | Medical Technologies Innovation Facility

PANELLISTS INCLUDE

CHRIS MORTON | Chief Executive Officer | ELEM Biotech
DANIEL YAZDI | Medical Director | Bodyport
NICK CLARKE | Principal Advisor | Eastern Academic Health Science Network
FOZIA AHMED | Consultant Cardiologist | Manchester University NHS Foundation Trust

HTA playbook 2.0

How will changes in processes and methods of health technology assessment impact on an already essential step in the market access journey ?

FACILITATED BY

MARK CAMPBELL | Independent Healthtech Consultant

PANELLISTS INCLUDE

MICHELLE GREEN | Project Director | York Health Economics Consortium (YHEC)
ANDREW DAVIES |Digital Health Lead | ABHI
SYLVAIN PIQUET | Co-founder | Sharp Therapeutics
CHRIS CHESTERS | Senior HTA Adviser | NICE

Health and wealth

How has the uptake of technology eased the human and financial burden on the healthcare system?

FACILITATED BY

HANNAH DAVIES| Head of External and Public Affairs| Northern Health Science Alliance

PANELLISTS INCLUDE

JANEZ BENSA | Chief Executive Officer| Parsek
HARPREET SOOD | Global Digital Health Advisor and Non-executive Director | eRB and Health Education England
ANDREW THELWELL | Chief Commercial Officer | Sky Medical Technology
DAVID BRETTLE | Chief Scientific Officer | Leeds Teaching Hospitals NHS Trust

Lost in translation

What is preventing the clinical adoption of med and health tech? How can we develop technologies to ensure they translate into clinical practice?

 

FACILITATED BY

NEIL EBENEZER|  Medical Technologist Specialist |  Department for International Trade

PANELLISTS INCLUDE

LIZ ASHALL-PAYNE | Founding Chief Executive Officer | ORCHA
RACHEL NEAMAN | Technology Leader, Non-Executive Director, Leadership Mentor and Coach | Neaman Consulting
LORNA GREEN | Director of Enterprise & Growth | Innovation Agency
ALAN SUMNER |Head of Public Affairs and Market Access | Roche Diagnostics UK & Ireland
ALISTAIR (ALLY) LONGMUIR | Medical Technology & IVD Strategy Advisor | CPI

Surgery 4.0

The future transformation in surgical care will be driven by data and information. The key elements on the path toward evidence-based surgery are new tools to measure, model, and quantify surgical processes including intraoperative decision-making and knowledge extraction. How will digital technologies impact on surgical procedures and in the operating theatre over the next decade?

FACILITATED BY

CERI WILLIAMS | Director of Research and Innovation Development | University of Leeds

PANELLISTS INCLUDE

MARK SLACK | Co-Founder and Chief Medical Officer | CMR Surgical
DANIEL LEFF | Reader in Breast Surgery and Consultant Oncoplastic Breast Surgeon | Imperial College London
MALCOLM BROWN | Medical Lead | AMRC with Boeing, University of Sheffield
JAN-PHILIPP MOHR | Founder & Chief Executive Officer | Darvis

Closing Remarks with Darren Clarke

Chief Executive, Medilink Midlands